Filter
4023
Filtered Results: 4023
Text search:
Guidelines
Tuberculose
Featured
Recommendations
383
New Publications
1258
Language
Document type
No document type
2567
Guidelines
548
Studies & Reports
461
Manuals
184
Strategic & Response Plan
118
Training Material
50
Fact sheets
49
Situation Updates
21
Resource Platforms
12
Infographics
7
Brochures
4
App
1
Online Courses
1
Countries / Regions
India
225
Kenya
129
South Africa
104
Tanzania
94
Uganda
93
Global
89
Nepal
87
Ethiopia
86
Nigeria
83
Western and Central Europe
79
Malawi
77
Zambia
70
Liberia
59
Rwanda
58
Ghana
57
Bangladesh
56
Myanmar / Burma
53
Africa
50
Indonesia
49
Sierra Leone
48
Namibia
47
Brazil
44
Latin America and the Carribbean
43
Eastern Europe
43
Ukraine
39
Colombia
38
Argentina
37
Senegal
36
Lesotho
35
Paraguay
35
Philippines
34
Cambodia
33
Mozambique
32
Congo, Democratic Republic of
31
Zimbabwe
28
Peru
28
Asia
26
Botswana
25
Haiti
23
Russia
23
Burkina Faso
22
South–East Asia Region
22
Benin
19
Venezuela
18
Bolivia
17
Germany
15
El Salvador
15
Central African Republic
12
East and Southern Africa
12
South Sudan
11
Cameroon
10
Pakistan
10
Syria
10
Eswatini/ Swaziland
10
Chile
10
West and Central Africa
9
Ecuador
8
Madagascar
8
Georgia
8
Angola
7
Albania
7
Tajikistan
7
Guinea
6
Guinea-Bissau
6
Yemen
6
Eastern Europe and Central Asia
6
Somalia
5
Thailand
5
Sudan
5
Middle East and North Africa
5
Mali
4
Saudi Arabia
4
Jordan
4
Lebanon
4
Papua New Guinea
4
Armenia
4
Timor Leste/ East Timor
4
Moldova
4
Vietnam
4
North America
4
Afghanistan
3
North Macedonia
3
Burundi
3
Western Pacific Region
3
Southern Africa
3
Laos
3
Estonia
3
Morocco
2
USA
2
Togo
2
Iraq
2
Gambia
2
Hungary
2
Honduras
2
Mexico
2
Sri Lanka
2
Bhutan
2
Djibouti
2
Romania
2
Iran
2
Uruguay
2
Jamaica
2
Japan
2
Belgium
2
Portugal
2
Spain
2
Côte d’Ivoire / Ivory Coast
1
Niger
1
Egypt
1
Chad
1
China
1
Dominican Republic
1
Switzerland
1
Greece
1
Libya
1
Guatemala
1
Nicaragua
1
Other region
1
Luxembourg
1
Solomon Islands
1
Poland
1
Palestine
1
North Korea
1
Congo-Brazzaville
1
Canada
1
Qatar
1
Uzbekistan
1
Kyrgyzstan
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Tunisia
1
United Kingdom
1
Norway
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
1977
Clinical Guidelines
350
Public Health
187
Women & Child Health
154
Key Resources
102
Pharmacy & Technologies
53
Capacity Building
46
Annual Report MEDBOX
1
Toolboxes
TB
703
HIV
545
COVID-19
187
AMR
153
Pharmacy
82
Caregiver
74
Mental Health
68
Rapid Response
66
NCDs
66
Ebola
53
NTDs
52
Planetary Health
43
Refugee
42
Conflict
40
Global Health Education
32
Polio
28
Disability
24
Health Financing Toolbox
20
Natural Hazards
16
Zika
7
Cholera
2
Specific Hazards
2
Social Ethics
2
Health Financing
1
This document provides a systematic approach in developing a coordinated, standardized, reliable, efficient, cost-effective, and sustainable specimen transport and referral system to support IVHD and VL testing networks. This document provides technical and programmatic recommendations on the approp...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS function...
This study aimed to estimate the proportion of Mozambicans eligible for pharmacological treatment for hypertension according to single risk factor and total cardiovascular risk approaches. It concluded that a total of 19.8% of 40–64-year-olds would be eligible for pharmacological treatment of hype...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the ... and laws of their country of practice. Some medications may not be available in some countries and readers should consult the specific drug information since not all the unwanted effects of medications are mentioned.
A case study from Bosnia and Herzegovina Eurasian Harm Reduction Network
The case study was prepared by Samir Ibisevic, President of PROI between March and June 2016 and edited by Graham Shaw.
EHRN is grateful to all who contributed to this document, especially: Dr. Serifa Godinjak, Chairperson...
SDG target 3.3: by 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, waterborne diseases and other communicable diseases.
The report discusses the epidemiological and social aspects of ageing, health and functional changes experienced with ageing, the impact of physical activity, assessment of the nutritional status of older persons, and nutritional guidelines for heal...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, ...is, typhoid, cholera, meningitis, gonorrhea, and dysentery. Recognizing the urgent need for action, the World Health Assembly adopted the Global Action Plan on Antimicrobial Resistance in May 2015. In accordance with the Global Action Plan and to meet needs specific to Africa, Africa CDC will establish the Anti-Microbial Resistance Surveillance Network (AMRSNET). AMRSNET is a network of public health institutions and leaders from human and animal health sectors who will collaborate to measure, prevent, and mitigate harms from AMR organisms.
Reports of antimicrobial-resistant (AMR) microorganisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for human immunodeficiency virus (HIV) and the pathogens that cause mala...
The objective of this project was to list the medical devices required to provide the essential reproductive, maternal, newborn and child health interventions defined by existing WHO guidelines and publications, in order to improve access to these d...
This document synthesizes key elements of the World Health Organization (WHO) normative guidance on health policy and system support for community health worker (CHW) programmes and their application for HIV programmes. Building on relevant elements of HIV ..., tools and evidence identified by experts, it provides recommendations on tasks and roles that can be performed by CHWs (including for HIV), identifies the policy and system supports to optimize CHW performance, and gives examples of best practice. Its purpose is to inform the optimal design and delivery of CHW programmes targeting – either specifically or as part of a broader approach – the scale-up and sustainability of HIV services.
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or ...is.1 The impacts of medication errors also represent a
burden for health systems, with the annual cost associated with medication errors estimated at USD 42 billion
worldwideharm
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommend...
The increasing amounts of official development assistance (ODA) for health have been aimed primarily at fighting HIV/AIDS, malaria and tuberculosis. Neglected tropical diseases (NTD), one of the most serious public health burdens among the most depr...
Japan has been implementing projects of global extension of medical technologies under an official development assistance policy to improve public health and medicine by promoting Japanese medical technologies worldwide. The current work examines the impact and goals of implementing this new scheme....
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium ...is and Vibrio cholerae, antimicrobial resistance (AMR)). The decrease in cost and time of sequencing and the exponential development of bioinformatic pipelines have played a critical role in integrating pathogen genomics into routine public health surveillance. The coronavirus disease 2019 (COVID-19) pandemic has highlighted the role that sequencing plays in the surveillance of infectious diseases. Sequencing facilitates earlier detection, more accurate investigation of outbreaks, closer real-time monitoring of pathogen evolution and tailored development and evaluation of interventions to inform local to global public health decision-making and action. However, there remains a need to coordinate efforts, leverage and link existing surveillance and laboratory networks and capabilities, and systematically integrate genetic sequence data (GSD) with clinical and epidemiological data to strengthen its utility.
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced COPD-related exacerbations, associated hospitalisati...
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing...
This document provides a list of key WHO-recommended maternal and newborn health commodities and aims to accelerate progress towards the SDGs. It consolidates the key and enabling commodities from existing WHO guidelines on maternal and newborn heal...
